上海招聘

职位描述：
Established in 1989, OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm. OrbiMed manages approximately USD$13 billion assets and has invested in over 450 companies across a wide range of therapeutic categories and stages of development. From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. For more information, please visit our website: www.orbimed.com
We are looking for an intern to support the work of our public equity team. The requirements are as follows:
1. Financial, managerial/ biological, Medical, Pharmaceutical dual-background is preferred
2. from a prestigious university, postgraduate is preferred
3. Able to work at least 3 days per week for 3 months. Candidate who can start as soon as possible is preferred
4. Graduate in or later than 2019
5. Quick learner who is hardworking, with good English skills
6. Excellent analytical skills, good at Excel, PPT
7. Familiar with various financial tools
Please send us your CV as attachment to the following mail address: asiainfo@orbimed.com , with "Intern _ Name _ University _ Grade" as the subject. Please highlight your earliest available working time in the email (e.g. 4 days/week, for 4-5 months from Nov.2017).
OrbiMed Shanghai office is located in the area of Peoples’ Square.

奥博资本(OrbiMed)创立于1989年，是全球最大的专注于生物医疗领域的投资公司,目前管理约130亿美元的资产，在全球成功投资了450多家企业。奥博资本致力于寻找和支持能够促进人类健康的生物医疗和生命科学企业。我们专注于全球生物医疗领域的投资已有二十多年，投资项目涵盖生物制药、生命科技、医疗器械、医疗服务及诊断等领域，投资阶段覆盖初创期、成长期、成熟期及上市后。更多信息请见www.orbimed.com
基于业务的快速发展，我司上海办公室二级市场团队招聘实习生一名，要求如下：
1.有经管和生物、医学、药学等复合背景优先
2.上海本地名校在校生, 研究生优先
3.实习期至少3个月, 每周至少三天
4.2019年或以后毕业
5.学习能力强, 勤奋踏实, 英文能力好
6.拥有良好的分析能力，擅长Excel, PPT；
7. 熟练掌握各项金融工具
应聘者请将简历以附件的形式发送电子邮件至：asiainfo@orbimed.com ，邮件标题请注明“Intern+您的姓名_院校名称_年级”，并请在邮件中标明您最快能够到岗的时间。
奥博资本上海办公室位于交通便利的人民广场地区。 举报 分享

About OrbiMed

Established in 1989, OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm. OrbiMed manages approximately USD$11 billion assets, including several PE/VC funds, hedge funds and mutual funds. Since the inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 170 private companies across a wide range of therapeutic categories and stages of development, over 100 of which have been either listed or acquired. OrbiMed’s investment team includes over 80 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed Asia, with offices in Shanghai and Mumbai, manages OrbiMed Asia Partners (OAP), the first pan-Asia healthcare and life sciences-dedicated private equity fund. OAP has made PE investments in 24 companies, with close to USD$500 million under management. OrbiMed has also invested approximately USD$200M in the stocks of public China healthcare companies.